Back to top
more

Hologic (HOLX)

(Delayed Data from NSDQ)

$80.24 USD

80.24
1,245,584

+1.02 (1.29%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $80.25 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 24% (61 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Accuray TomoTherapy System Starts Cancer Treatment in Africa

Accuray Inc. (ARAY) recently announced that the Radiotherapy and Medical Oncology Center of Sidi Abdellah, Algeria has finally initiated cancer treatment with the company's flagship TomoTherapy system.

    ResMed's Study Results for Central Sleep Apnea Hold Promise

    ResMed Inc. (RMD) recently sponsored a study which shows potential treatment of obstructive sleep apnea (OSA) in patients with untreated central sleep apnea (CSA).

      athenahealth (ATHN) Allies with CoverMyMeds for Faster ePA

      athenahealth Inc. (ATHN) recently entered into a strategic partnership with CoverMyMeds.

        DaVita Banks on Acquisitions, Escalating Expenses a Concern

        On Apr 10, we issued an updated research report Denver, CO-based DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure.

          Masimo (MASI) Launches Root Platform with Kite Trademark

          Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).

            AngioDynamics (ANGO) Prices 2.5M Secondary Share Offering

            AngioDynamics, Inc. (ANGO) announced that it has priced its underwritten public offering of 2.35 million shares of common stock.

              ABIOMED (ABMD) Banks on Impella Platform, Forex a Concern

              On Apr 7, we issued an updated research report on Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer.

                Hill-Rom's Innovations Make Surgeries More Safe, Accurate

                Hill-Rom Holdings, Inc. (HRC) recently demonstrated the impact of surgical patient positioning on skin and nerve pressure-related injuries.

                  PetMed Faces Concerns over New Order Sales, Competition

                  On Apr 6, we issued an updated research report on Pompano Beach, FL-based PetMed Express, Inc. (PETS).

                    athenahealth Now a Strong Buy: Should You Add the Stock?

                    On Apr 5, athenahealth (ATHN) was raised to a Zacks Rank #1 (Strong Buy).

                      Medidata & TESARO Win CARE 'Clinical Partnership' Award

                      Medidata Solutions Inc. (MDSO) recently announced the receipt of the 'Clinical Partnership of the Year' award at the second annual Clinical and Research Excellence (CARE) Awards, courtesy of its 'unique technology collaboration' with TESARO.

                        Omnicell's Aesynt Buyout Looks Promising amid Several Woes

                        On Apr 6, we issued an updated research report on Mountain View, CA-based Omnicell Inc. (OMCL).

                          David Bartosiak headshot

                          Crude Bucks Choppy Trend - Dave's Daily Dive

                          Crude bucked the choppy trend in markets today as equities sloshed back-and-forth most of the day

                            Tirthankar Chakraborty headshot

                            New Strong Buy Stocks for April 4th

                            Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Tuesday

                              Hologic Completes Cynosure Buyout, Boosts Core Business

                              Hologic, Inc. (HOLX) recently announced the completion of it earlier declared acquisition of marketer of aesthetic treatment systems, Cynosure, Inc.

                                Cynosure (CYNO) to be Acquired by Hologic in $1.65B Deal

                                Cynosure, Inc. (CYNO), announced that it has entered into a definitive merger agreement with Hologic, Inc. (HOLX).

                                  Hologic (HOLX) Beats on Q1 Earnings, Lowers '17 Guidance

                                  Hologic Inc. (HOLX) reported first-quarter fiscal 2017 adjusted earnings per share (EPS) of 52 cents, up 13% year over year.

                                    Medical Instrument Stocks' Earnings on Feb 1: EW, HOLX, BABY

                                    Already more than one-third of the S&P 500 members (170 companies making up for 19.2% of the total market cap) have reported their Oct--Dec 2016 quarter's earnings results.

                                      John Blank headshot

                                      4 Good Reasons to Focus on the USA: Global Week Ahead

                                      In the Global Week Ahead, the bulk of any trader???s time should focus on the good ol' USA. Why do we think that? There are four old-fashioned reasons.

                                        Abiomed (ABMD) Beats Earnings & Revenue Estimates in Q3

                                        Abiomed Inc. (ABMD) reported third-quarter fiscal 2017 earnings of 34 cents per share, which surpassed the Zacks Consensus Estimate by 5 cents and surged 47.8% from the year-ago quarter.

                                          C.R. Bard (BCR) Q4 Earnings & Sales Better Than Expected

                                          C.R. Bard Inc. (BCR) reported adjusted earnings of $2.77 in the fourth quarter of 2016, exceeding the Zacks Consensus Estimate by 4 cents and improving from the year-ago quarterly number of $2.43.

                                            Quality Systems (QSII) Beats on Earnings & Revenues in Q3

                                            Irvine, CA-based Quality Systems Inc. (QSII) reported third-quarter fiscal 2017 adjusted earnings of 21 cents per share, exceeding the Zacks Consensus Estimate of 18 cents.

                                              Varian Medical (VAR) Misses on Q1 Earnings and Revenues

                                              Varian Medical Systems, Inc. (VAR) reported adjusted earnings of 75 cents per share in the first quarter of fiscal 2017.

                                                McKesson (MCK) Beats on Earnings in Q3, Inks Buyout Deal

                                                McKesson Corporation (MCK) reported third-quarter fiscal 2017 earnings of $3.03 per share, beating the Zacks Consensus Estimate of $2.95 but declining from the year-ago figure of $3.18.

                                                  Stryker (SYK) Beats Q4 Earnings, Provides FY17 Guidance

                                                  Maintaining its streak of positive earnings surprises, Stryker Corp (SYK) reported adjusted earnings of $1.78 per share in the fourth quarter of 2016, which comfortably beat the Zacks Consensus Estimate by 2 cents.